CompletedPhase 4

Treatment of Acute Pseudophakic Cystoid Macular Edema: Bromfenac 0.09% Versus Diclofenac Sodium 0.1% Versus Ketorolac Tromethamine 0.5%

United States166 participantsStarted 2008-01

Plain-language summary

To compare bromfenac 0.09%, diclofenac sodium 0.1%, and ketorolac tromethamine 0.5% ophthalmic solutions for the treatment of acute pseudophakic CME after cataract surgery.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients must be diagnosed with acute pseudophakic CME within 12 months of cataract surgery * Males and females 18 years and older * Able to provide written informed consent Exclusion Criteria: * Complicated cataract surgery, particularly posterior capsule rupture and vitreous loss * Pre-Existing macular pathology, including macular edema, macular scar, macular hole, or macular pucker * History of Uveitis * Ipsilateral intraocular surgery prior to cataract surgery * CME greater than one year duration

What they're measuring

Acute Pseudophakic Cystoid Macular Edema

Timeframe: 5 months

Trial details

NCT IDNCT00595543

SponsorBp Consulting, Inc

Sponsor typeNETWORK

Study typeINTERVENTIONAL

Primary completion2009-03

View on ClinicalTrials.gov More Acute Pseudophakic Cystoid Macular Edema trials